We have just had a win in addressing Alzheimer’s among people with Down syndrome. The FDA has FDA given full approval for the use a new drug, Leqembi, for the treatment of early Alzheimer’s disease. And the Centers for Medicare and Medicaid Services (CMS) has announced they will provide reimbursement for the drug.
